共 13 条
[1]
Plasma Aβ, homocysteine, and cognition: The Vitamin Intervention for Stroke Prevention (VISP) trial[J] . A Viswanathan,S Raj,S M. Greenberg,M Stampfer,S Campbell,B T. Hyman,M C. Irizarry.  Neurology . 2009 (3)
[2]
Meta-Analy-sis of Folic Acid Supplementation Trials on Risk of Cardiovascu-lar Disease and Risk Interaction With Baseline HomocysteineLevels. Miller ER 3rd,Juraschek S,Pastor-BarrIuso R,et al. The American Journal of Cardiology . 2010
[3]
Homocysteine as a risk fac-tor for development of microalbuminuria in type 2 diabetes. Cho EH,KimEH,KimWG,et al. Korean Diabetes . 2010
[4]
Hyperhomocysteinemia in poorly controlled type 2 diabetes patients. Drzewoski J,Czupryniak L,Chwatko G,et al. Diabetes Nutrition Metabolism . 2000
[5]
Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Soinio M,Marniemi J,Laakso M,et al. Annals of Internal Medicine . 2004
[6]
Restenosis after angioplasty. Cannon,RO. The New England Journal of Medicine . 2002
[7]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[8]
E ffect of homocysteine-loweringtherapy w ith folic Acid,vitam in B12,and vitam in B6 on clin ical outcom eafter percutaneous coronary intervention:the sw iss heart study:a ran-dom ized controlled trial〔J〕. Schnyder G,RoffiM,Flamm er Y,et al. The Journal of The American Medical Association . 2002
[9]
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[10]
Low total plasma homocysteine, centrations in patients withtyoe 1 diabetes. Cotellessa M,Minniti G,CeroneR, et al. Diabetes Care . 2001